Objective: We tested the hypothesis that cerebral amyloid angiopathy (CAA) is related to Alzheimer disease (AD) dementia and decline in multiple cognitive systems in old age, independent of AD plaque and tangle pathology and other common age-related neuropathologies.Methods: Participants (n 5 1,113) came from 2 longitudinal clinical-pathologic studies of aging, the Rush Memory and Aging Project and the Religious Orders Study. All underwent annual clinical evaluations including detailed cognitive testing for a mean of 7.1 years before death. Clinical diagnoses of AD were established after reviewing all clinical data, blinded to neuropathologic information. Neuropathologic examinations provided measures of CAA, AD pathology, macroscopic infarcts, microinfarcts, and neocortical Lewy bodies. The association of CAA with AD dementia was examined using logistic regression models, and its association with cognitive decline was examined using linear mixed models.Results: CAA was common, present in 78.9% of participants, and moderately related to AD pathology (r 5 0.401, p , 0.0001). In analyses adjusted for plaques, tangles, and other common age-related neuropathologies, CAA was associated with an increased odds of AD dementia (odds ratio 5 1.237, 95% confidence interval 1.082-1.414) and an increased rate of decline in global cognition, perceptual speed, episodic memory, and semantic memory. The associations of CAA with cognitive outcomes were not driven by the presence of capillary involvement.Conclusions: CAA is an important determinant of AD dementia and decline in multiple cognitive systems in old age. Cerebral amyloid angiopathy (CAA) is frequently observed in the brains of older persons and cooccurs with Alzheimer disease (AD) pathology.1,2 However, the independent relation of CAA with late-life cognitive outcomes is unclear. Although several studies suggest a link between CAA and dementia, 3-7 findings come mainly from highly selected samples, and AD and other common age-related neuropathologies have infrequently been considered. [8][9][10][11] Furthermore, little is known about the relation of CAA with cognitive decline. We previously reported associations between CAA, perceptual speed, and episodic memory proximate to death in a sample a third the size of that in this study, 12 but studies examining the relation of CAA with the rate of change in multiple cognitive systems over time are rare.We tested the hypothesis that CAA is related to cognitive outcomes over and above other common age-related neuropathologies, particularly AD. Participants and data came from 2 longitudinal clinical-pathologic studies of aging. 13 We first examined the independent relation of CAA with likelihood of AD dementia, and then examined the association of CAA with cognitive decline using data collected annually for up to 19 years before death.METHODS Standard protocol approvals, registrations, and patient consents. Data for this study came from 2 ongoing longitudinal cohort studies of aging. 13,14 These studies were approved b...